Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

Insurance incentives might help smokers quit, study says

23.02.2005


Health insurance that pays the full cost of smoking-cessation treatments can increase quit rates, compared to benefit plans that pick up only part of the tab or that offer no cessation benefits at all, according to a new review of studies.



Smokers receiving full benefits were one-and-a-half times more likely to quit successfully and nearly one-and-a-half times more likely to try quitting than those receiving no benefit, according to review authors Janneke Kaper of Maastricht University in the Netherlands and colleagues.

The actual increase in quit rates was slight, however. In studies where a full benefit was compared to no benefit, abstinence rates among smokers rose 2 percentage points, Kaper says. "In this economically minded time, determining the effectiveness of an intervention is no longer enough to justify its use," Kaper says. "As health care costs increase and resources are limited, it is also important to determine whether financial support for smoking-cessation treatment is cost-effective."


The "relatively low costs" of providing full benefits for smoking cessation varied between $260 and $2,330 per quitter, compared to partial or no benefits, the researchers say.

The review appears in the latest issue of The Cochrane Library, a publication of The Cochrane Collaboration, an international organization that evaluates medical research. Systematic reviews draw evidence-based conclusions about medical practice after considering both the content and quality of existing medical trials on a topic.

Previous research shows that smoking-cessation treatment, including counseling, nicotine replacement products and the antidepressant drug bupropion can increase the chances that a smoker will give up the habit.

But "costs are a significant barrier to the use of smoking-cessation treatment. Healthcare providers may be deterred from offering treatment if they do not receive reimbursement, and patients may be deterred if they must pay for treatment costs," Kaper says.

Kaper and colleagues reviewed evidence from six high-quality studies of financial incentives directed at smokers and one study that looked at the effects of incentives paid to clinics that actively identified smokers and documented advice to quit.

Incentives such as full insurance coverage for smoking-cessation therapies slightly improved quit rates, the studies showed, but the payments to clinics did not improve quit rates significantly.

There were also no signs that the incentives had caused the clinics to change their usual advice and care for smokers. Studies of financial incentives directed at health care providers are almost non-existent "probably because there are simply no such incentive systems," Kaper says.

"Governments and health insurance companies try to control medical expenditures. Rewarding health care providers for increasing their number of prescriptions may contradict their policy," she suggests.

Some health care system managers have suggested that "removing financial barriers to treatment would lead to less motivated smokers using treatment services, such that quit rates would go down," according to smoking cessation researcher Sue Curry.

In light of this, "the finding in the review that full financial benefits actually increased cessation rates is quite encouraging," says Curry, who is the director of the Institute for Health Research and Policy at the University of Illinois at Chicago.

Kaper says the review’s findings should be interpreted with caution because the studies varied significantly in the people, places and health care systems that were examined.

Although Kaper and colleagues suggest that financial support can increase the proportion of smokers who use quit therapies, Curry says history may suggest otherwise, in that mammography screening rates, for example, continue to lag even after most insurance began to cover the procedure, Curry says.

"I would focus future research on ways of increasing use of treatment, given full coverage," Curry says.

Janneke Kaper | EurekAlert!
Further information:
http://www.unimaas.nl
http://www.cochrane.org
http://www.cfah.org

More articles from Studies and Analyses:

nachricht Do microplastics harbour additional risks by colonization with harmful bacteria?
05.04.2018 | Leibniz-Institut für Ostseeforschung Warnemünde

nachricht Rutgers-led innovation could spur faster, cheaper, nano-based manufacturing
14.02.2018 | Rutgers University

All articles from Studies and Analyses >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Spider silk key to new bone-fixing composite

University of Connecticut researchers have created a biodegradable composite made of silk fibers that can be used to repair broken load-bearing bones without the complications sometimes presented by other materials.

Repairing major load-bearing bones such as those in the leg can be a long and uncomfortable process.

Im Focus: Writing and deleting magnets with lasers

Study published in the journal ACS Applied Materials & Interfaces is the outcome of an international effort that included teams from Dresden and Berlin in Germany, and the US.

Scientists at the Helmholtz-Zentrum Dresden-Rossendorf (HZDR) together with colleagues from the Helmholtz-Zentrum Berlin (HZB) and the University of Virginia...

Im Focus: Gamma-ray flashes from plasma filaments

Novel highly efficient and brilliant gamma-ray source: Based on model calculations, physicists of the Max PIanck Institute for Nuclear Physics in Heidelberg propose a novel method for an efficient high-brilliance gamma-ray source. A giant collimated gamma-ray pulse is generated from the interaction of a dense ultra-relativistic electron beam with a thin solid conductor. Energetic gamma-rays are copiously produced as the electron beam splits into filaments while propagating across the conductor. The resulting gamma-ray energy and flux enable novel experiments in nuclear and fundamental physics.

The typical wavelength of light interacting with an object of the microcosm scales with the size of this object. For atoms, this ranges from visible light to...

Im Focus: Basel researchers succeed in cultivating cartilage from stem cells

Stable joint cartilage can be produced from adult stem cells originating from bone marrow. This is made possible by inducing specific molecular processes occurring during embryonic cartilage formation, as researchers from the University and University Hospital of Basel report in the scientific journal PNAS.

Certain mesenchymal stem/stromal cells from the bone marrow of adults are considered extremely promising for skeletal tissue regeneration. These adult stem...

Im Focus: Like a wedge in a hinge

Researchers lay groundwork to tailor drugs for new targets in cancer therapy

In the fight against cancer, scientists are developing new drugs to hit tumor cells at so far unused weak points. Such a “sore spot” is the protein complex...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

VideoLinks
Industry & Economy
Event News

Invitation to the upcoming "Current Topics in Bioinformatics: Big Data in Genomics and Medicine"

13.04.2018 | Event News

Unique scope of UV LED technologies and applications presented in Berlin: ICULTA-2018

12.04.2018 | Event News

IWOLIA: A conference bringing together German Industrie 4.0 and French Industrie du Futur

09.04.2018 | Event News

 
Latest News

Magnetic nano-imaging on a table top

20.04.2018 | Physics and Astronomy

Start of work for the world's largest electric truck

20.04.2018 | Interdisciplinary Research

Atoms may hum a tune from grand cosmic symphony

20.04.2018 | Physics and Astronomy

VideoLinks
Science & Research
Overview of more VideoLinks >>>